Compare PLUR & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLUR | RMTI |
|---|---|---|
| Founded | 2001 | 1994 |
| Country | Israel | United States |
| Employees | N/A | 300 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.5M | 26.7M |
| IPO Year | 2001 | 2022 |
| Metric | PLUR | RMTI |
|---|---|---|
| Price | $2.09 | $0.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | $2.00 |
| AVG Volume (30 Days) | 10.1K | ★ 371.5K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,336,000.00 | ★ $69,258,000.00 |
| Revenue This Year | $97.38 | $8.64 |
| Revenue Next Year | $293.97 | $8.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 309.82 | N/A |
| 52 Week Low | $1.99 | $0.55 |
| 52 Week High | $5.96 | $2.10 |
| Indicator | PLUR | RMTI |
|---|---|---|
| Relative Strength Index (RSI) | 37.48 | 27.76 |
| Support Level | N/A | N/A |
| Resistance Level | $2.58 | $1.00 |
| Average True Range (ATR) | 0.12 | 0.04 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 22.73 | 0.40 |
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.